Filing Details
- Accession Number:
- 0001209191-22-048920
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-06 20:48:53
- Reporting Period:
- 2022-09-01
- Accepted Time:
- 2022-09-06 20:48:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1832529 | Debkishore Mitra | C/O Lucira Health Inc. 1412 62Nd St. Emeryville CA 94608 | Chief Technology Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-09-01 | 191 | $1.69 | 382,208 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 10, 2021 for 8,250 shares.
Billionaire Hedge Funds
